1-3 of 3
Elaine Hurt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First Disclosure of AZD9829, a TOP1i-ADC Targeting CD123: Promising Preclinical Activity in AML Models with Minimal Effect on Healthy Progenitors

Dipannita Dutta, Pan Pan, Ryan Fleming, Marcio Andrade-Campos, Elena Belova, Jennifer Wheeler, Patricia Cheung, Paul Santacroce, Casey Daniels, Darrin Sabol, Brad Jakubison, Benedicte Recolin, Andrew Dippel, Margaret Wey, Arthur Shaffer, Edward Rosfjord, Elaine Hurt, Gullu Gorgun, Anas Younes, Puja Sapra
Journal: Blood
Blood (2023) 142 (Supplement 1): 5957.
https://doi.org/10.1182/blood-2023-187642
Published: 2023
Journal Articles

Discovery and Development of MEDI7247, a Novel Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugate Targeting ASCT2, for Treating Hematological Cancers

Nabendu Pore, Kevin P Schifferli, Noel R Monks, Ravinder Tammali, Martin Borrok, Elaine Hurt, Matt Flynn, Marlon Rebelatto, Danielle M. Townsley, MD MSc, Mary Jane Hinrichs, Rakesh Dixit, Steven Coats, Ronald Herbst, David Tice
Journal: Blood
Blood (2018) 132 (Supplement 1): 4071.
https://doi.org/10.1182/blood-2018-99-119836
Published: 2018
Journal Articles

Preclinical Evaluation of MEDI2228, a BCMA-Targeting Pyrrolobenzodiazepine-Linked Antibody Drug Conjugate for the Treatment of Multiple Myeloma

Krista Kinneer, John Meekin, Reena Varkey, Xiaodong Xiao, Haihong Zhong, Shannon Breen, Elaine Hurt, Suneetha Thomas, Matt Flynn, Paul Hynes, Binyam Bezabeh, Cui (Tracy) Chen, Leslie Wetzel, Ruoyan Chen, Yu-Tzu Tai, PhD, Kenneth C Anderson, MD, Ronald Herbst, David Tice
Journal: Blood
Blood (2017) 130 (Supplement 1): 3153.
https://doi.org/10.1182/blood.V130.Suppl_1.3153.3153
Published: 2017